Boson Rapid SARS-CoV-2 Antigen Test Card
- This device is authorized by Health Canada’s under the Interim Order – Authorization #323096, so it’s in-line with the license issued for this medical device.
- Lab Based* —— For professional use
- Quantity: 20 tests/kit
- Sample type: Nasal swab
- Storage temperature: 2–30°C
- Shelf life: 18 months
- Test time: 15–20 minutes (do not read results after 20 minutes)
- Back order now, in stock by Mid-Febuary
*Lab-based tests are conducted in a lab environment by a trained laboratory technician. Point-of-care testing devices are used by an approved operator (often a health care professional) in a near-patient environment like a medical office or at the bedside. The patient waits for the results. Self-testing devices are those that can be purchased and used by the general public.
Rapid SARS-CoV-2 Antigen Test Card is a lateral flow immunoassay intended for the comparative detection of nucleocapsid protein from SARS-CoV-2 in nasopharyngeal swab specimens.
High Accuracy: nasopharyngeal swab collection with clinically proven high accuracy results
Affordability: Any qualified Health Care professionals can easily use our three-step, cost-effective portable testing kit
Easy to use: Testing can be easily administered in almost any environment without additional special equipment. Easy to transport with no special storage requirements, a test kit is all you need.
Rapid Results: Compared to standard RT-PCR tests which could take multiple days for patients to receive their results, Boson Antigen testers will show results within 15–20 minutes.
Quantity: 20 tests/kit
Sample type: Nasopharyngeal swab
Storage temperature: 2–30°C
Shelf life: 18 months
Test time: 15–20 minutes (do not read results after 20 minutes)
Diagnostic Sensitivity: 93.75%
Diagnostic Specificity: 98.4%
Shelf Life (expiration): 18 months
Storage Temperature: 2-30°C/36-86°F
IO authorization Device identifier : 061254/09167/1N40C5/1N40T0
- 20 Rapid SARS-CoV-2 Antigen Test Cards (Individually packaged)
- 2 Sample Buffer
- 20 Sterilized nasopharyngeal swabs (Individually packaged)
- 20 Extraction tubes (Individually packaged)
- 1 Instruction for use
- 1 Tube rack (for 6 tubes/rack)
POC authorized use guidelines may vary by province so please contact your local regulators for confirmation on local professional use requirements.
Returns PolicyYou may return most new, unopened items within 30 days of delivery for a full refund. We'll also pay the return shipping costs if the return is a result of our error (you received an incorrect or defective item, etc.).
You should expect to receive your refund within four weeks of giving your package to the return shipper, however, in many cases you will receive a refund more quickly. This time period includes the transit time for us to receive your return from the shipper (5 to 10 business days), the time it takes us to process your return once we receive it (3 to 5 business days), and the time it takes your bank to process our refund request (5 to 10 business days).
If you need to return an item, simply login to your account, view the order using the 'Complete Orders' link under the My Account menu and click the Return Item(s) button. We'll notify you via e-mail of your refund once we've received and processed the returned item.
ShippingWe can ship to virtually any address in the world. Note that there are restrictions on some products, and some products cannot be shipped to international destinations.
When you place an order, we will estimate shipping and delivery dates for you based on the availability of your items and the shipping options you choose. Depending on the shipping provider you choose, shipping date estimates may appear on the shipping quotes page.
Please also note that the shipping rates for many items we sell are weight-based. The weight of any such item can be found on its detail page. To reflect the policies of the shipping companies we use, all weights will be rounded up to the next full pound.
Rapid SARS-CoV-2 Antigen Test Card is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein from SARS-CoV-2 in nasopharyngeal swab specimens from individuals who are suspected of COVID-19 by their healthcare provider within the first 7 days of symptom onset.